Kerstin Rebrin

Kerstin is responsible for developing and executing Profusa’s Medical and Clinical strategies. Dr. Rebrin is a seasoned physician scientist with clinical and research experience in the field of diabetes and other metabolic diseases. She is known for her pioneering translational research toward an artificial pancreas introducing continuous glucose sensing and therapy algorithms based on glucose monitoring for various routes of insulin delivery. She is highly competent in end-to-end development of class II and III sensing and drug delivery devices and executing clinical development strategies for product registration and market introduction in various jurisdictions. Before joining Profusa, Dr. Rebrin led projects and teams in small and large medical device companies: Medtronic MiniMed, Abbott Diabetes Care, MicroChips, Becton Dickinson and Roche. Dr. Rebrin received her medical degrees and education from the 2nd Medical University “N.I. Pirogov”, Moscow, Russia, the Medical University of Lübeck, Germany and the Institute for Diabetes “Gerhardt Katsch”, Karlsburg Germany. She came to the United States for postdoctoral work at the University of Southern California.